Glimepiride (Amaryl) and Ketamine Therapy | Tovani Health
Amaryl (Glimepiride) — Sulfonylurea antidiabetic
Verdict at Tovani Health
Fully compatible; the hypoglycemia consideration is a fasting-window logistics issue, not a KAP interaction.
Glimepiride and ketamine have no clinically significant pharmacokinetic or pharmacodynamic interaction. The practical thing to plan around is the pre-session fasting window typical for KAP — sulfonylureas can cause hypoglycemia and the fast amplifies that risk. We coordinate dosing with you (often holding the AM dose on session day, then resuming with food after). Same framework as glipizide and glyburide.
If you take Amaryl regularly and are considering at-home ketamine therapy, the combination is generally safe at therapeutic doses. This page covers the brief pharmacologic context and what we do at intake.
How Amaryl interacts with ketamine
Glimepiride stimulates insulin release from pancreatic beta cells. Long half-life produces sustained insulin secretion. No direct ketamine PK interaction.
What we do at intake
Disclose your dose and recent A1c. Plan to hold or reduce the session-day morning dose with your prescriber; bring a glucose source. Once-daily dosing means a held dose is recoverable.
Bottom line
Glimepiride and ketamine have no clinically significant pharmacokinetic or pharmacodynamic interaction. The practical thing to plan around is the pre-session fasting window typical for KAP — sulfonylureas can cause hypoglycemia and the fast amplifies that risk. We coordinate dosing with you (often holding the AM dose on session day, then resuming with food after). Same framework as glipizide and glyburide.
Ready to find out if at-home ketamine fits your situation?
We’ll note that you’re on Amaryl (Glimepiride) at intake. The eligibility check takes 5 minutes and gives you an honest answer about whether at-home ketamine fits your specific situation.
FL and NJ residents only. Benjamin Soffer, DO — Tovani Health.
Clinically reviewed
Reviewed by Benjamin Soffer, DO on May 22, 2026. Dr. Soffer is a board-certified physician (American Board of Internal Medicine) licensed in Florida and New Jersey, prescribing at-home ketamine therapy through Tovani Health.
This page is general information about how this medication interacts with at-home ketamine therapy at Tovani Health. It is not a substitute for medical advice from your prescribing physician about your specific situation. Always discuss medication changes with the doctor who prescribed them.